Skip to content
10-Q

Quarterly Report

QUANTRX BIOMEDICAL CORPORATION

0001654954-21-005834

← back to feed
Filed
May 17, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · May 17, 2021 78.7M sh
Cash And Equivalents Q1 2021 · Mar 31, 2021 $48.5K
Cash And Equivalents Q1 2021 · Dec 31, 2020 $55.43K
Cash And Equivalents Q1 2021 · Mar 31, 2020 $111.98K
Cash And Equivalents Q1 2021 · Dec 31, 2019 $130.35K
Current Liabilities Q1 2021 · Mar 31, 2021 $2.49M
Current Liabilities Q1 2021 · Dec 31, 2020 $2.44M
Total Liabilities Q1 2021 · Mar 31, 2021 $2.49M
Total Liabilities Q1 2021 · Dec 31, 2020 $2.44M
Current Assets Q1 2021 · Mar 31, 2021 $48.5K
Current Assets Q1 2021 · Dec 31, 2020 $55.43K
Total Assets Q1 2021 · Mar 31, 2021 $48.5K
Total Assets Q1 2021 · Dec 31, 2020 $55.43K
Operating Cash Flow Q1 2021 · Mar 31, 2020 −$18.38K
Stockholders Equity Q1 2021 · Mar 31, 2020 −$2.17M
Stockholders Equity Q1 2021 · Dec 31, 2019 −$2.13M
Sga Expense Q1 2021 · Mar 31, 2020 $3.9K
Net Income Q1 2021 · Mar 31, 2020 −$44.67K
Operating Income Q1 2021 · Mar 31, 2020 −$15.4K